Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03250429 · ClinicalTrials.gov registry record
Nasal and Peripheral Blood Biomarkers of CRS Patients Before and After Surgical Intervention
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 30
- Enrollment target
NCT03250429: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT03250429 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03250429 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
To characterize inflammatory cells in the nose of patients with Chronic Rhinosinusitis (CRS) before and after sinus surgery.
Primary Outcome
Detection and analysis of inflammatory mediators previously characterized in CRS subgroups, including but not limited to Transforming growth factor beta 1 (TGFβ1), Interferon gamma (IFNγ), Interleukin 5 (IL-5), Interleukin 17 (IL-17), eosinophil cationic protein (ECP), mast cell tryptase, and Interleukin (IL-10) from the nasal mucosa.
Interventions
- PROCEDURE Sinus surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2019-12-20 |
What the finished NCT03250429 record still lists
NCT03250429 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Sinus surgery is the first listed.
NCT03250429 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03250429 about?
NCT03250429 is a clinical study titled "Nasal and Peripheral Blood Biomarkers of CRS Patients Before and After Surgical Intervention". To characterize inflammatory cells in the nose of patients with Chronic Rhinosinusitis (CRS) before and after sinus surgery.
What is the current status of trial NCT03250429?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2017-09-01. Estimated completion is 2019-12-20.
What interventions are being tested in trial NCT03250429?
The interventions under investigation include: Sinus surgery (PROCEDURE).
Who is sponsoring clinical trial NCT03250429?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI